Citi Credit Research initiated coverage of Valeant Pharmaceuticals International Inc. (NYSE: VRX) with an Overweight rating sending the stock price soaring $11.40 to close at $84.00.
Valeant initiated with Overweight
November 19, 2015 at 16:23 PM EST
